Journal article
Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC
- Publication status:
- Published
Actions
Authors
- Journal:
- JOURNAL OF CLINICAL ONCOLOGY More from this journal
- Volume:
- 26
- Issue:
- 15
- Publication date:
- 2008-05-20
- ISSN:
-
0732-183X
- Pubs id:
-
pubs:356500
- UUID:
-
uuid:f4526b1c-f4b7-43d4-a931-58c7aaa75c4b
- Local pid:
-
pubs:356500
- Source identifiers:
-
356500
- Deposit date:
-
2013-11-17
- ARK identifier:
Terms of use
- Copyright date:
- 2008
If you are the owner of this record, you can report an update to it here: Report update to this record